InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Wilkins H Jeffrey, Directeur Médical. Officer active across 3 companies, notably Cerecor Inc.. Cumulatively, 4 filings have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €21k. History available since 10 June 2021. The latest transaction was disclosed on 10 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
6,371 shares@ US$1.5750.0% of flowCommon StockSEC:0001879785-21-000041
Ideal exit: 6 Sept 2022 (T+270)
6,371 shares@ US$1.570.0026% mcap50.0% of flowCommon StockSEC:0001879785-21-000041:0
Ideal exit: 6 Sept 2022 (T+270)
912 shares@ US$2.28100.0% of flowCommon StockSEC:0001192482-21-000498
Ideal exit: 7 Mar 2022 (T+270)
912 shares@ US$2.28100.0% of flowCommon StockSEC:0001192482-21-000498:0
Ideal exit: 7 Mar 2022 (T+270)
4 of 4 declarations
About Wilkins H Jeffrey
H. Jeffrey Wilkins is the Chief Medical Officer at Cerecor Inc. and Avalo Therapeutics, Inc. He is responsible for the medical direction and clinical strategy of these companies. H. Jeffrey Wilkins leverages his expertise to ensure that medical products and services meet quality and safety standards. His role is essential in supporting innovation and research in the healthcare field.
